Aguilar-Cordova, C. E., Macklin, R., Markert, M. L., Mickelson, C. A., Ando, D. G., Breakefield, X. O., … Levi-Pearl, S. L. (2002). U.S. Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee: Minutes of meeting: December 6, 2001. Human Gene Therapy, 13(13), 1663–1673. https://doi.org/10.1089/10430340260201752

Aguilar-Cordova, C. E., R. Macklin, M. L. Markert, C. A. Mickelson, D. G. Ando, X. O. Breakefield, T. C. Friedmann, et al. “U.S. Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee: Minutes of meeting: December 6, 2001.” Human Gene Therapy 13, no. 13 (September 27, 2002): 1663–73. https://doi.org/10.1089/10430340260201752.

Aguilar-Cordova CE, Macklin R, Markert ML, Mickelson CA, Ando DG, Breakefield XO, et al. U.S. Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee: Minutes of meeting: December 6, 2001. Human Gene Therapy. 2002 Sep 27;13(13):1663–73.

Aguilar-Cordova, C. E., et al. “U.S. Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee: Minutes of meeting: December 6, 2001.” Human Gene Therapy, vol. 13, no. 13, Sept. 2002, pp. 1663–73. Scopus, doi:10.1089/10430340260201752.

Aguilar-Cordova CE, Macklin R, Markert ML, Mickelson CA, Ando DG, Breakefield XO, Friedmann TC, Gordon JW, Greenblatt JJ, Juengst ET, King NMP, Levi-Pearl SL. U.S. Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee: Minutes of meeting: December 6, 2001. Human Gene Therapy. 2002 Sep 27;13(13):1663–1673.